The present disclosure is generally related to Cannabis product labels and more specifically related to crowdsourcing Cannabis product labels for descriptive onset of effects.
Labeling Cannabis products correctly is of huge importance. Mislabeling Cannabis products can cause great harm to users. Many dispensaries and online stores are currently offering mislabeled Cannabis products that have incorrect information in regards to their potency. Certain states, such as California, have introduced law regarding the packaging of Cannabis to address the rampant mislabeling and lack of uniformity of product labeling among growers, producers, and retail sellers of Cannabis. Such exemplar laws would require a thorough investigation into the potency mislabeling issues. For example, California's investigation in such safety concerns have resulted in the discovery that nearly a fifth of products retailing in California's dispensaries were found to be falsely labeled, as 18% of the products in California have failed tests for potency (concentration of cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD)) and purity. Of the 11,000 samples that were tested, almost 2,000 failed.
Testing is especially poor on infused products. Examples of infused products are Cannabis infused brownies, tinctures, extracts, and similar products, which are traditionally very potent. Reports indicated that nearly a third of those products should be removed from the retail market for labeling that claimed levels of cannabinoids that were different from what was found during testing. False claims of THC contents accounted for 65 percent of the failures as 1,279 out of a total of 10,695 tests failed. Most importantly, there is evidence that the growers are correctly testing and labeling the Cannabis flowers prior to processing. For example, in California, approximately 90% of the Cannabis flowers tested turned out to be factually correct when compared to its label, indicating a mostly accurate labeling by the growers.
Another factor to mislabeling is that testing products (e.g., analytical chemistry testing for potency) can be cost prohibitive for small Cannabis farms and manufacturers. Costs of testing products for small Cannabis grow operation can range around $5,000 to $10,000 USD depending on the number of products and testing locations. For California, the mandatory testing of Cannabis is conducted by the California Bureau of Cannabis Control, which is a state government body. However, such uniformity is not necessarily available in other states or countries.
Labels on Cannabis product are also subject to government-required health disclosures. For example Health Canada released its proposals for Cannabis packaging that requires a standardized Cannabis warning symbol and a series of government-mandated messages warning of the potential health risks of Cannabis. Such messages may be “WARNING: Cannabis can be addictive,” “Up to 1 in 2 people who use Cannabis daily will become addicted,” “WARNING: Adolescents are at greater risk of harms for Cannabis,” or “Early and regular use increases the risk of psychosis and schizophrenia.” These warnings may be useful in conveying the long-term health implications of Cannabis use but do very little to address the specific onset of effects associated with consuming the Cannabis product.
There exists a need to provide Cannabis users with a product label that accurately describes the onset of effects associated with the consumption of a specific Cannabis product. Health and safety labels are a necessary feature of a Cannabis product label but do little to inform a medical or recreational user of relative effects of different Cannabis products. Allowing product manufacturers to create their own labeling schema is likely to disjoint the Cannabis recreational product labeling market, making it difficult for users to compare products from different manufacturers. Furthermore, there exists a need to provide users with a standardized labeling system to compare various Cannabis products, report products that are mislabeled, and provide feedback to the labeling system to improve labels over time. Such a system should allow product manufacturers to include a standard effects label on their Cannabis product, where data for the label may be collected by a focus group or crowdsourced by various Cannabis consumers who can provide feedback to the labeling system.
Embodiments of the present disclosure include systems and methods for providing Cannabis product labels describing the onset of effects.
The system 100 may be understood as a network in the cloud or internet that may aggregate data from several sources that result in producing a Cannabis product label that accurately describes the onset of effects of a particular Cannabis product. For example, one of the possible sources of this data is from users who submit descriptions of the onset of effects after consuming the Cannabis product through the label network 102. Other users may also use the label network 102 to access the aggregated data.
The label network 102 may consist of a label database 104, a crowdsource software module 106, a comparison module 108, a user database 110, and a manufacturer software module 112. The label database 104 may include a database of information that may be placed on Cannabis product labels. Such information may include the onset of effects of the labeled products, and other Cannabis product data such as ingredients, testing results, user reviews, etc. The crowdsource software module 106 may then receive user submitted descriptions of the onset of effects, aggregating the descriptions, and comparing the description to the current product label to determine if the product label must be updated. The comparison software module 108 may then compare the collected data on the onset of effects for particular Cannabis from the crowdsource module 106 to predict whether a user will likely favorably tolerate that particular Cannabis product based on the user's profile (e.g., experience level) in the user database 110. For example, after analyzing a user's profile and a Cannabis product aggregated data, the comparison module 108 may indicate that the product is not recommended for the user because of the user's experience level.
The user database 110 may include a database of users and a profile for each user, which may include data on each user's experience level, history of Cannabis usage, and previously submitted descriptions of the onset of effects of Cannabis products. The manufacturer software module 112 may receive product data from a Cannabis product manufacturer, provide labeling guidelines to the manufacturer for a product label that describes the onset of effects, and allow the manufacturer data associated with a specific product to be scanned and reviewed by users of the label network 102.
The user device 114 is a device that may contain a label scanner 116 that is capable of scanning Cannabis product labels, and that is capable of downloading and executing a software application that may include a network module 118, and a usage module 120. Once the user device 114 downloads the software application, the user device 114 may then be used to retrieve product data, input descriptions of the onset of effects, and track the user's history of Cannabis usage. The label scanner 116 may allow a Cannabis product label to be scanned to connect with the network module 118 to retrieve the data associated with the scanned product. Examples of possible technology in a user device 114 that may operate as a label scanner 116 may include a camera, optical sensor, barcode scanner, NFC, RFID, or some other method of scanning a label for a unique product code.
The network module 118 is a software module of an application on the user device 114 that may retrieve product data from the label network 102 and send user data including a description of the onset of effects to the label network. The usage module 120 is a software module of an application on the user device 114 that allows the user to input and track the user's Cannabis usage and experience. The usage module 120 may be connected with the network module 118 to provide the user inputted usage data to the label network 102, allowing the label network 102 to compare the user's history of consumption/usage.
The Cannabis product package 122 is a package that contains the Cannabis product 132 and product label 124. The package 122 can be in any number of forms. For example, the package may be a bag, tote, box, rigid packaging, medical bottle, food wrapper, or some other method of packaging a Cannabis product that allows a label to be affixed. The product label 124 is label that contains information that is unique to the Cannabis product that the label is affixed to. The information on the product label 124 may include a barcode or similarly scan-able feature 126, a description of the onset of effects 128, and a recommended user experience level 130. The scan-able portion 126 of the product label 124 may allow the user to retrieve product information from the label network 102, compare the user's history of Cannabis usage, and allow the user to submit a description of the onset of effect.
The product label's description of Cannabis effects 128 may include the time from consumption when effects may first present, the sensations associated with the onset of effects (e.g., physical, psychological/emotional), the recommendation of activities most suitable during the onset of effects, and the time from consumption when the effects may begin to dissipate. The recommended experience level 130 of the product label 124 is a recommendation of the level of experience the user should have before consuming the Cannabis product. Some examples of experience level may include beginner, intermediate, expert, high tolerance, very high tolerance/Cannabis resistant, and the regularity or quantity the user typically consumes (e.g., daily, weekly, monthly, yearly consumer, 1 gram of Cannabis per day, week, or month, etc.). The Cannabis product 132 is the product described by the product label and contained within the packaging. The product 132 may be whole Cannabis plant, dried Cannabis flower, pre-rolled Cannabis cigarettes, Cannabis extract, concentrate or oil, a Cannabis food or beverage product, tincture, patch, vaporizing liquid, topical ointment, crystallized powder, wax or resin, etc.
The manufacturing network 134 may include a product database 136, a label module 138, and a label database 140. The manufacturer network 134 may be a network in the cloud that allows a product manufacturer to send product data from the product database 136 to the label network 102 to be accessed by the user via the user device 114. The manufacturing network 134 may also receive from the label network 102 labeling guidelines for each product, which may then be stored in the label database 140.
The product database 136 is a database on the manufacturer network 134 that contains product data for each Cannabis product produced by a manufacturer. The label module 138 is a software module of the manufacturer network 134 that allows the manufacturer network 134 to send product data to the label network 102. The label network 102 may then internally test, review, or allow users to test and review the specific Cannabis product. After testing and reviewing, the label network 102 may then provide the manufacturer network 134 with labeling guidelines for the specific Cannabis product. The label database 140 is a database of product label guidelines received from the label network 102 that also identifies the associated product in the product database 136.
If a similar product was found, the comparison module 108 will send the comparison to the user device 114 at step 410. The comparison may include the similarities and differences between the previously consumed product and the current product. If no similar product is found, the comparison module may analyze user's experience level stored in the user database at step 412. The user's experience level may be based on self-reported tolerance, inferred from the products the user has previously reviewed or usage data stored in the user profile. The comparison module 108 may then compare user experience level to the scanned product based on potency, or experience level of other users who have consumed the Cannabis product, at step 414.
The comparison module 108 will then analyze whether the user is experienced enough to consume product at step 416. For example, the module will analyze whether the user's experience level is the same or greater than the experience level recommended for the product. If the user is not experienced enough, the comparison module 108 will send a warning to the user device 114 that the product may be inappropriate for the user at step 418. In an embodiment, the warning may specify that the product potency may be too high for the user. In another embodiment, the warning may suggest alternative similar products with lower potency for the user to consume. If the user has the appropriate experience, the comparison module 108 will send a recommendation to the user device 114 to cautiously try the new product and submit a review at step 420.
The foregoing detailed description of the technology has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the technology to the precise form disclosed. Many modifications and variations are possible in light of the above teaching. The described embodiments were chosen in order to best explain the principles of the technology, its practical application, and to enable others skilled in the art to utilize the technology in various embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the scope of the technology be defined by the claims.
The present patent application is a continuation of International Application No. PCT/IB2019/058961 filed Oct. 22, 2019, which claims the priority benefit of U.S. provisional patent application 62/750,198 filed Oct. 24, 2018, the disclosures of which are incorporated by reference herein.
| Number | Date | Country | |
|---|---|---|---|
| 62750198 | Oct 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/IB2019/058961 | Oct 2019 | US |
| Child | 17239790 | US |